Skip to main content
$57.19 -$1.05 (-1.8%)

11:59 AM EDT on 10/27/21

Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Current Price $57.19 Mkt Cap $129.4B
Open $58.35 P/E Ratio 0.00
Prev. Close $58.24 Div. (Yield) $1.96 (3.4%)
Daily Range $56.11 - $58.42 Volume 8,549,391
52-Wk Range $56.11 - $69.75 Avg. Daily Vol. 10,617,561

Caps

How do you think NYSE:BMY will perform against the market?

Add Stock to CAPS Watchlist

All Players

1,831 Outperform
113 Underperform
 

All-Star Players

272 Outperform
17 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:BMY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

johnclanaro (< 20)
Submitted October 28, 2013

recent upgrade. good pipeline.

msabol01 (83.94)
Submitted April 02, 2017

Strong pipeline and a culture that wants to innovate. Strong focus on patients. Leadership seems to struggle with launching products and being competitive out the door. Long term will either find BMY on strong footing or acquired.

Recent Community Commentary

Read the most recent pitches from players about BMY.

Recs

0
Member Avatar BRIDividends (< 20) Submitted: 10/25/2021 4:29:15 PM : Outperform Start Price: $57.72 NYSE:BMY Score: -1.15

The BRI Dividend portfolio includes S&P500 stocks that meet the following criteria:

- Dividend Growth for 10 or more years;
- Dividend Chowder (dividend yield plus 5 year dividend growth rate) of 7% or more;
- Payout Ratio (earnings based) of less than 60; and
- Passes certain BRI screenings (including certain weapons, alcohol, tobacco, gambling, certain medical products and immoral businesses).

The resulting portfolio should be a mix of large blue chip dividend growth companies that meet biblically responsible investing criterias.

Recs

0
Member Avatar Craigs22 (48.70) Submitted: 10/4/2021 12:15:19 AM : Outperform Start Price: $59.40 NYSE:BMY Score: -8.90

Extremely attractive valuation for a company with a strong existing set of drugs and upside in their pipeline

Recs

0
Member Avatar asdfk123 (53.48) Submitted: 9/30/2021 12:32:58 PM : Outperform Start Price: $42.00 NYSE:BMY Score: -15.17

Added to position @$59.72 per share.

Leaderboard

Find the members with the highest scoring picks in BMY.

Score Leader

d3lta4ce

d3lta4ce (< 20) Score: +255.45

The Score Leader is the player with the highest score across all their picks in BMY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
3750399 22.63 2/17/2009 Underperform NS $13.71 +317.83% +479.00% +161.17 0 Comment
GuruMF3 67.43 6/27/2016 Underperform 5Y $59.74 -4.13% +128.56% +132.69 0 Comment
KlownKollegeGrad 43.74 1/6/2012 Underperform 1Y $25.51 +124.56% +256.37% +131.81 0 Comment
GuruMF6 53.83 5/10/2016 Underperform 5Y $60.76 -5.74% +120.61% +126.35 0 Comment
GuruMF5 76.96 5/10/2016 Underperform 5Y $60.76 -5.74% +120.61% +126.35 0 Comment
GuruMF4 65.67 6/13/2016 Underperform 3W $61.24 -6.47% +118.36% +124.83 0 Comment
Biotechnut < 20 7/9/2012 Underperform 5Y $26.23 +118.39% +236.86% +118.47 0 Comment
Nacho2k 79.35 6/13/2008 Outperform 3Y $12.28 +366.31% +248.02% +118.29 0 Comment
tnovosad < 20 6/13/2008 Outperform NS $12.29 +365.85% +247.69% +118.17 0 Comment
99FE905 < 20 6/20/2008 Outperform 5Y $12.11 +372.96% +255.17% +117.79 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BMY.